Showing results (51-60 of 96) with videos related to
Sort By:
Pageof 10
Plos One|April 28, 2017
Novel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccinesNicola Borthwick, Zhansong Lin, Tomohiro Akahoshi, et al.Oncotarget|February 3, 2017
Loss of PFKFB4 induces cell death in mitotically arrested ovarian cancer cellsCharlotte Taylor, David Mannion, Fabrizio Miranda, et al.Plos One|October 4, 2007
Design and pre-clinical evaluation of a universal HIV-1 vaccineSven Létourneau, Eung-Jun Im, Tumelo Mashishi, et al.Archives of Gynecology and Obstetrics|October 22, 2008
Baseline characteristics and prevalence of HPV 6, 11, 16, 18 in young German women participating in phase III clinical trials of a quadrivalent HPV (6/11/16/18) vaccineElisabeth Barthell, Linn Woelber, Karin Hellner, et al.AIDS (London, England)|July 30, 2005
Therapeutic immunization of highly active antiretroviral therapy-treated HIV-1-infected patients: safety and immunogenicity of an HIV-1 gag/poly-epitope DNA vaccineLucy Dorrell, Hongbing Yang, Astrid Kn Iversen, et al.Hepatology (Baltimore, Md.)|February 4, 2020
Characterizing Hepatitis C Virus-Specific CD4+ T Cells Following Viral-Vectored Vaccination, Directly Acting Antivirals, and Spontaneous Viral CureFelicity Hartnell, Ilaria Esposito, Leo Swadling, et al.Journal of Virology|March 27, 2015
Early Kinetics of the HLA Class I-Associated Peptidome of MVA.HIVconsv-Infected CellsNicola Ternette, Peter D Block, Álvaro Sánchez-Bernabéu, et al.HIV Medicine|March 4, 2022
Re-valuation of annual cytology using HPV self-sampling to upgrade prevention (REACH UP): A feasibility study in women living with HIV in the UKPaola Cicconi, Charlotte Wells, Blanka McCarthy, et al.The Journal of Experimental Medicine|December 8, 2004
T cell cross-reactivity and conformational changes during TCR engagementJean K Lee, Guillaume Stewart-Jones, Tao Dong, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2007
Broad TCR usage in functional HIV-1-specific CD8+ T cell expansions driven by vaccination during highly active antiretroviral therapyHongbing Yang, Tao Dong, Emma Turnbull, et al.Pageof 10